Coya Therapeutics, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Coya Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $19.14K.
- Coya Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $19.14K, a 868.96% increase year-over-year.
- Coya Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $1.98K.
- Coya Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-03-31 was $158.00.
- Coya Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $38.27K, a 1837.92% increase from fiscal 2024.
- Coya Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $1.98K, a 97.80% decline from fiscal 2023.
- Coya Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $89.95K, a 56828.48% increase from fiscal 2022.
- Coya Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $158.00, a 50.16% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-12-31 | $38.27K 10-K · filed 2026-03-16 | |
| 2025-09-30 | $19.14K 10-Q · filed 2025-11-12 | |
| 2025-03-31 | $19.14K 10-Q · filed 2026-08-11 | |
| 2024-12-31 | $1.98K 10-K · filed 2026-03-16 | |
| 2024-03-31 | $1.98K 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $89.95K 10-K · filed 2025-03-18 | |
| 2022-12-31 | $158.00 10-K · filed 2024-03-19 | |
| 2022-03-31 | $158.00 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $317.00 10-K · filed 2023-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |